
|Videos|November 10, 2022
Update on adjuvant treatment of bladder cancer
Author(s)Urology Times staff
“The bar is high; we want to be curing these patients, not just delaying a recurrence of their cancer,” says Arlene O. Siefker-Radtke, MD.
Advertisement
In this video, Arlene O. Siefker-Radtke, MD, discusses recent developments in the adjuvant treatment of bladder cancer. Siefker-Radtke is a professor of Genitourinary Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston. She was interviewed at the
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA reports increased demand, supply efforts for estradiol transdermal patches
2
The UroOnc Minute: Perioperative Intravesical Chemotherapy at Nephroureterectomy, With Surena F. Matin, MD, FACS
3
What the Efficacy Data from KEYNOTE-B15/EV-304 Revealed
4
NeoBLAST trial tests active surveillance after complete response in MIBC
5











